We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
-5.56%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$168M
AUM Growth
-$23.1M
Cap. Flow
-$95M
Cap. Flow %
-56.41%
Top 10 Hldgs %
59.36%
Holding
73
New
14
Increased
9
Reduced
26
Closed
17

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$5.13M
2
GS icon
Goldman Sachs
GS
+$3.86M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$1.89M
4
JPM icon
JPMorgan Chase
JPM
+$1.64M
5
ZVRA icon
Zevra Therapeutics
ZVRA
+$1.4M

Sector Composition

Rank Sector Weight
1 Healthcare 60.15%
2 Financials 9.03%
3 Communication Services 6.38%
4 Materials 4.94%
5 Industrials 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LQD icon
26
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35.2B
$1.63M 0.97%
13,740
+8,320
+154% +$956K
IWF icon
27
iShares Russell 1000 Growth ETF
IWF
$123B
$1.41M 0.84%
+56,480
New +$1.33M
IVW icon
28
iShares S&P 500 Growth ETF
IVW
$73.1B
$1.39M 0.83%
+48,040
New +$1.32M
GOOG icon
29
Alphabet (Google) Class C
GOOG
$4.22T
$1.25M 0.74%
33,540
-8,980
-21% -$322K
META icon
30
Meta Platforms (Facebook)
META
$1.64T
$1.1M 0.65%
9,649
-2,589
-21% -$273K
GBT
31
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.03M 0.61%
+65,000
New +$1.15M
GOOGL icon
32
Alphabet (Google) Class A
GOOGL
$4.23T
$959K 0.57%
25,140
-6,760
-21% -$249K
ICPT
33
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$899K 0.53%
7,000
IGV icon
34
iShares Expanded Tech-Software Sector ETF
IGV
$13.8B
$869K 0.52%
+43,180
New +$817K
PTLA
35
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$765K 0.45%
37,500
+12,500
+50% +$397K
EEM icon
36
iShares MSCI Emerging Markets ETF
EEM
$28B
$639K 0.38%
18,660
-9,105
-33% -$282K
ORCL icon
37
Oracle
ORCL
$364B
$629K 0.37%
15,386
-4,128
-21% -$153K
IBM icon
38
IBM
IBM
$200B
$622K 0.37%
4,296
-1,153
-21% -$147K
SHY icon
39
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
$556K 0.33%
6,540
-10,560
-62% -$896K
AAPL icon
40
Apple
AAPL
$4.9T
$536K 0.32%
19,704
-3,324
-14% -$82.8K
TIP icon
41
iShares TIPS Bond ETF
TIP
$14.5B
$509K 0.3%
4,440
-780
-15% -$87.1K
SPY icon
42
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$504K 0.3%
+2,450
New +$478K
GOOG icon
43
CALL
Alphabet (Google) Class C
GOOG
$4.22T
$386K 0.23%
+200,000
New +$7.16M
UNH icon
44
UnitedHealth
UNH
$387B
$341K 0.2%
2,650
-1,012
-28% -$120K
MDT icon
45
Medtronic
MDT
$106B
$312K 0.19%
4,149
-1,584
-28% -$119K
GE icon
46
GE Aerospace
GE
$364B
$306K 0.18%
2,006
-252
-11% -$35.6K
UEC icon
47
Uranium Energy
UEC
$4.59B
$244K 0.14%
+326,420
New +$281K
XOM icon
48
ExxonMobil
XOM
$611B
$242K 0.14%
2,895
+58
+2% +$4.64K
PYPL icon
49
PayPal
PYPL
$49.9B
$230K 0.14%
5,942
-1,594
-21% -$57.6K
XLK icon
50
State Street Technology Select Sector SPDR ETF
XLK
$114B
$222K 0.13%
+10,018
New +$207K

Similar funds

DSC Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, DSC Advisors held 73 positions worth $168M, down 12% from $191M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

DSC Advisors withdrew a net $95M in Q1 2016, closing 17 positions and reducing 26 holdings. Its most notable exit was Accelerate Diagnostics, an estimated $2.45M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 66% a quarter earlier, followed by Financials and Communication Services.

Against the trend, DSC Advisors opened a new position in Aptiv worth $5.63M.

  • DSC Advisors's largest Q1 2016 buy was Aptiv: 75,000 shares worth $5.63M.
  • DSC Advisors added most to Goldman Sachs in Q1 2016, an estimated $3.86M increase.
  • DSC Advisors's biggest Q1 2016 reduction was CVS Health, cutting an estimated $6.43M.
  • DSC Advisors fully exited Accelerate Diagnostics in Q1 2016, selling an estimated $2.45M.
  • DSC Advisors's ten largest holdings make up 59% of its $168M portfolio in Q1 2016.
  • DSC Advisors opened 14 new positions and closed 17 in Q1 2016.
  • DSC Advisors's portfolio value fell 12% quarter-over-quarter to $168M.

Based on DSC Advisors's 13F filing for Q1 2016, filed 16 May 2016.